COVID-19 Treatment Review


COVID-19 Treatments? Please don’t call your doctor for any! ##medical ##COVID19 ##shelterinplace ##bayarea ##docintegrative

♬ Sum 2 Prove – Lil Baby

Hello all, here is a timely review of COVID-19 treatments currently being investigated. Everything is still under investigation, but we have reason to be hopeful!

  • Hydroxychloroquine (study underway in South Korea)
  • Lopinavir/ritonavir (studied in China)
  • Remdesivir (study underway in USA, including Stanford)
    • Intravenous broad spectrum antiviral with in-vitro activity against SARS-CoV-2 (used on compassionate basis)
    • Also currently in clinical trial for Ebola infections
  • Methylprednisolone (ongoing study in China)
    • Decreased risk of death in patients exhibiting severe lung complications (ARDS)*
  • Monoclonal antibodies
    • May mitigate effects of cytokine storm observed in some patients
    • Tocilizumab (study underway in Italy), Sarilumab (study underway in New York)

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Mar 13.

Leave a Reply